Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases

Código QR

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases

Guardado en:

Detalles Bibliográficos
Autores principales:	Cosimo Bruni, Cosimo Cigolini, Giulia Tesei, Laura Cometi, Francesca Bartoli, Ginevra Fiori, Francesca Nacci, Silvia Bellando-Randone, Serena Guiducci, Marco Matucci-Cerinic
Formato:	article
Lenguaje:	EN
Publicado:	AVES Yayincilik 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/f80be4e28ec645649f0ff644ea8d4d44
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
por: Carlos Sánchez-Piedra, et al.
Publicado: (2021)

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Stopeck AT, et al.
Publicado: (2012)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
por: Riccardo Terenzi, et al.
Publicado: (2017)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013)

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: E Michael Lewiecki
Publicado: (2008)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Tomonori Kobayakawa, et al.
Publicado: (2021)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis
por: Esteban A. Gomez, et al.
Publicado: (2020)

Hypercalcemia following discontinuation of denosumab therapy: A systematic review
por: Keisuke Horiuchi, et al.
Publicado: (2021)

Clinical utility of denosumab for treatment of bone loss in men and women
por: Adler R, et al.
Publicado: (2011)

Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh AS, et al.
Publicado: (2015)

Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
por: A. Prior-Español, et al.
Publicado: (2021)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller CJ, et al.
Publicado: (2012)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati A, et al.
Publicado: (2021)

Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
por: Pedram Fadavi, et al.
Publicado: (2021)

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
por: Yee AJ, et al.
Publicado: (2012)

Alopecia Areata Incognita and Diffuse Alopecia Areata: Clinical, Trichoscopic, Histopathological, and Therapeutic Features of a 5-Year Study
por: Aurora Alessandrini, et al.
Publicado: (2019)

Chronic Kidney Disease and Dietary Supplementation: Effects on Inflammation and Oxidative Stress
por: Elisa Martello, et al.
Publicado: (2021)

Antiimperialismo, tecnología y petróleo en la novela venezolana
por: Mandrillo, Cósimo
Publicado: (2012)

EL CORAJE DE LA VERDAD
por: Cosimo Cascione
Publicado: (2020)

Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease
por: Scott E. Youlten, et al.
Publicado: (2021)

Walking down Skeletal Muscle Lane: From Inflammasome to Disease
por: Nicolas Dubuisson, et al.
Publicado: (2021)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Barbara Ruaro, et al.
Publicado: (2021)

The Role of Pathology in the Diagnosis of Swine Respiratory Disease
por: Giuseppe Sarli, et al.
Publicado: (2021)

Dietary Antioxidants and Metabolic Diseases
por: Alessandra Durazzo, et al.
Publicado: (2021)

Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis
por: Rosanna Villani, et al.
Publicado: (2021)

Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis
por: Yuko Kanbayashi, et al.
Publicado: (2021)

A Peculiar Case of Darier Disease in Blaschkoid Distribution
por: Francesca Peccerillo, et al.
Publicado: (2020)

Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease
por: Jason Wang, et al.
Publicado: (2021)

Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease
por: K. I. Watt, et al.
Publicado: (2021)

Exercise capacity correlates with thoracic skeletal muscle abnormalities in adults with congenital heart disease
por: Jacob Steffen, et al.
Publicado: (2021)

Analysis of smart contracts balances
por: Cosimo Laneve, et al.
Publicado: (2021)

Editorial to the Special Issue “MicroRNA in Solid Tumor and Hematological Diseases”
por: Francesca Lovat
Publicado: (2021)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
por: Ishikawa K, et al.
Publicado: (2018)

Polyclonal light chains in cerebrovascular disease
por: Patrizia Fiori, et al.
Publicado: (2010)

Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment
por: Yu Toda, et al.
Publicado: (2021)

Writing as teacher education
por: Cosimo Laneve, et al.
Publicado: (2016)

Cognitive and anatomical underpinnings of the conceptual knowledge for common objects and familiar people: a repetitive transcranial magnetic stimulation study.
por: Fabio Campanella, et al.
Publicado: (2013)